Form: SCHEDULE 13G

Statement of Beneficial Ownership by Certain Investors

August 11, 2025

EXHIBIT 99.1


JOINT FILING AGREEMENT


In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the common stock of 180 Life Sciences Corp. and further agree that this agreement be included as an exhibit to such filing.  Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement.  Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.


In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 11th day of August 2025.


FF Consumer Growth II, LP


By:

The Founders Fund Growth II Management, LP

Its:

General Partner


By:

FF Upper Tier GP, LLC

Its:

General Partner


By:  /s/ Peter Thiel

Name: Peter Thiel

Title:  Manager



The Founders Fund Growth II Management, LP


By:

FF Upper Tier GP, LLC

Its:

General Partner


By:  /s/ Peter Thiel

Name: Peter Thiel

Title:  Manager



FF Upper Tier GP, LLC


By:  /s/ Peter Thiel

Name: Peter Thiel

Title:  Manager


FF Consumer Growth, LLC


By:

The Founders Fund Growth Management, LLC

Its:

Manager


By:  /s/ Peter Thiel

Name: Peter Thiel

Title:  Manager



The Founders Fund Growth Management, LLC


By:  /s/ Peter Thiel

Name: Peter Thiel

Title:  Manager



Peter Thiel


/s/ Peter Thiel